Although the European Medicines Agency (EMA) recently approved a recombinant FVIIa (rFVIIa) for the treatment of acute bleeding in postpartum hemorrhage (PPH), its use is associated with risks of ...

Postpartum hemorrhage due to uterine atony is the primary direct cause of maternal mortality globally. Management strategies in developed countries involve crystalloid fluid replacement ...

A 33-year-old woman experienced a thunderclap headache immediately postpartum ... A subarachnoid hemorrhage was demonstrated on a head CT scan. Investigations. Physical examination, laboratory ...